Skip to main content
Log in

Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis

  • Translational Research and Biomarkers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to identify novel molecular markers for the early detection of colorectal cancer liver metastasis.

Methods

Genes related to hepatic metastasis were screened from the Oncomine database. The candidate markers were tested by immunohistochemistry, and their predictive accuracy was assessed by the cross-validation method and an independent test set.

Results

We got three datasets containing 2,973 genes that were highly expressed in primary colon cancer tissues compared with non-metastatic colon cancer tissues and identified 7 candidate molecules for immunohistochemical validation. A total of 213 colorectal cancer samples were randomly divided into a training set (113 cases) and a blind testing set (100 cases). In the training set, immunohistochemical analysis showed that HP, OPN, and PTGIS expression were significantly higher in the hepatic metastasis group than in the non-metastasis group. Logistic regression analysis showed that HP and OPN levels in primary tumors and lymph node metastasis status were the only significant (P < 0.05) parameters for detecting liver metastasis. The predictive accuracy of markers was assessed by the cross-validation method and an independent test set. In leave-one-out cross-validation, the two markers combined with clinicopathologic features resulted in 91.2% sensitivity and 96.4% specificity for hepatic metastasis detection. In an independent test set, the combination achieved 94.5% sensitivity and 88.9% specificity for predicting the hepatic metastasis of colorectal cancer.

Conclusions

Our results suggest that combined HP and OPN expression levels are significantly related to liver metastasis and prognosis, and, if this is validated, they could be used as accurate predictors of liver metastasis in colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay F, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–9.

    Article  PubMed  Google Scholar 

  3. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol. 2007;16:3–5.

    Article  PubMed  Google Scholar 

  4. Angelopoulos S, Kanellos I, Christophoridis E, Tsachalis T, Kanellou A, Betsis D. Five-year survival after curative resection for adenocarcinoma of the colon. Tech Coloproctol. 2004;8(Suppl. 1):S152–4.

    Article  PubMed  Google Scholar 

  5. Bakalakos EA, Kim JA, Young DC, Martin EW Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg. 1998;22:399–404; discussion 404–5.

    Article  PubMed  CAS  Google Scholar 

  6. Di Martino E, Wild CP, Rotimi O, Darnton JS, Olliver RJ, Hardie LJ. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett’s oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomarkers. 2006;11:547–61.

    Article  PubMed  CAS  Google Scholar 

  7. Yamazoe Y, Maetani S, Onodera H, Nishikawa T, Tobe T. Histopathological prediction of liver metastasis after curative resection of colorectal cancer. Surg Oncol. 1992;1:237–44.

    Article  PubMed  CAS  Google Scholar 

  8. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol. 2006;94:68–80.

    Article  PubMed  CAS  Google Scholar 

  9. Ohji Y, Yao T, Eguchi T, et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep. 2007;17:525–30.

    PubMed  CAS  Google Scholar 

  10. Barozzi C, Ravaioli M, D’Errico A, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer. 2002;94:647–57.

    Article  PubMed  CAS  Google Scholar 

  11. Takata O, Kawamura YJ, Konishi F, et al. cDNA array analysis for prediction of hepatic metastasis of colorectal carcinoma. Surg Today. 2006;36:608–14.

    Article  PubMed  CAS  Google Scholar 

  12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  13. Li M, Lin YM, Hasegawa S, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24:305–12.

    PubMed  Google Scholar 

  14. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6:1–6.

    PubMed  CAS  Google Scholar 

  15. Marquardt JU, Quasdorff M, Varnholt H, et al. Neighbor of punc E11, a novel oncofetal marker for hepatocellular carcinoma. Int J Cancer. 2010.

  16. Monami G, Emiliozzi V, Bitto A, et al. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol. 2009;174:1037–47.

    Article  PubMed  CAS  Google Scholar 

  17. Smith DD, Saetrom P, Snove OJ, et al. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bioinformatics. 2008;9:63.

    Article  PubMed  Google Scholar 

  18. Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS One. 2008;3:e3661.

    Article  PubMed  Google Scholar 

  19. Tanami H, Tsuda H, Okabe S, et al. Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab Invest. 2005;85:1118–29.

    Article  PubMed  CAS  Google Scholar 

  20. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg. 1996;131:322–9.

    Article  PubMed  CAS  Google Scholar 

  21. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49–54.

    Article  PubMed  CAS  Google Scholar 

  22. Hu H, Sun L, Guo C, et al. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res. 2009;15:5485–93.

    Article  PubMed  CAS  Google Scholar 

  23. Macri A, Versaci A, Lupo G, et al. Role of osteopontin in breast cancer patients. Tumori. 2009;95:48–52.

    PubMed  CAS  Google Scholar 

  24. Sun Y, Wang L, Jiang M, Huang J, Liu A, Wolfl S. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys. 2010;56:59–71.

    Article  PubMed  CAS  Google Scholar 

  25. Yu HB, Han XB, Liang YQ, Liu JG, Wang H. [Expression of osteopontin and survivin in prostate cancer and the clinical significance]. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30:1141–3.

    PubMed  CAS  Google Scholar 

  26. Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res. 2004;10(1 Pt. 1):184–90.

    Article  PubMed  CAS  Google Scholar 

  27. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44 V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007;67:2089–97.

    Article  PubMed  CAS  Google Scholar 

  28. Allan AL, George R, Vantyghem SA, et al. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol. 2006;169(1):233–46.

    Article  PubMed  CAS  Google Scholar 

  29. Ramankulov A, Lein M, Kristiansen G, Meyer HA, Loening SA, Jung K. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma. J Cancer Res Clin Oncol. 2007;133(9):643–52.

    Article  PubMed  CAS  Google Scholar 

  30. Huntoon KM, Wang Y, Eppolito CA, et al. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol. 2008;84:170–81.

    Article  PubMed  CAS  Google Scholar 

  31. Abdullah M, Schultz H, Kahler D, et al. Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathol Res Pract. 2009;205:639–47.

    Article  PubMed  CAS  Google Scholar 

  32. Smeets MB, Fontijn J, Kavelaars A, Pasterkamp J, De Kleijn DPV. The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues. Int J Exp Pathol. 2003;84:69–74.

    Article  PubMed  CAS  Google Scholar 

  33. Harvey S, Kohga S, Sait SN, et al. Co-expression of urokinase with haptoglobin in human carcinomas. J Surg Res. 2009;152:189–97.

    Article  PubMed  CAS  Google Scholar 

  34. Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clin Chim Acta. 2010;411:1116–21.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by The National Key Basic Research Program of China (2009CB521804 and 2010CB933902) and by PUMC&CAMS Funds for Young Scholar.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhihua Yang BS or Yuliang Ran PhD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 119 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, L., Pan, J., Peng, L. et al. Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis. Ann Surg Oncol 19, 2411–2419 (2012). https://doi.org/10.1245/s10434-011-2177-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-2177-2

Keywords

Navigation